Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Salvetti

Showing results (191-200 of 231) with videos related to

Pageof 24
Sort By:
Journal of Autoimmunity|February 13, 2026
Multiple sclerosis-associated EBNA2 variants influence the response to peginterferon beta-1a therapyCaterina Veroni, Fortunata Carbone, Daniela Ricci, et al.
European Journal of Neurology|May 8, 2023
Antibody response elicited by the SARS-CoV-2 vaccine booster in patients with multiple sclerosis: Who gains from it?Irene Schiavetti, Matilde Inglese, Jessica Frau, et al.
Neurology|June 8, 2018
Fingolimod vs dimethyl fumarate in multiple sclerosis: A real-world propensity score-matched studyLuca Prosperini, Matteo Lucchini, Shalom Haggiag, et al.
Journal of Neurology|March 28, 2022
Correction to: Prevalence and predictors of bowel dysfunction in a large multiple sclerosis outpatient population: an Italian multicenter studyAlvino Bisecco, Arianna Fornasiero, Assunta Bianco, et al.
CNS Drugs|July 20, 2018
Safety and Efficacy of Dimethyl Fumarate in Multiple Sclerosis: An Italian, Multicenter, Real-World StudyMassimiliano Mirabella, Luca Prosperini, Matteo Lucchini, et al.
Neurology|March 6, 2015
Epstein-Barr virus genetic variants are associated with multiple sclerosisRosella Mechelli, Caterina Manzari, Claudia Policano, et al.
European Journal of Neurology|September 10, 2022
Signs and symptoms of COVID-19 in patients with multiple sclerosisIrene Schiavetti, Luca Carmisciano, Marta Ponzano, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 20, 2022
Anti-SARS-CoV-2 T-stem cell memory persists in ocrelizumab-treated MS patientsGisella Guerrera, Alessandra Mandelli, Annamaria Finardi, et al.
Frontiers in Immunology|August 18, 2022
Proinflammatory mucosal-associated invariant CD8+ T cells react to gut flora yeasts and infiltrate multiple sclerosis brainFrancesca Gargano, Gisella Guerrera, Eleonora Piras, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 1, 2021
Charting a global research strategy for progressive MS-An international progressive MS Alliance proposalAlan J Thompson, William Carroll, Olga Ciccarelli, et al.
Pageof 24

Showing results (191-200 of 231) with videos related to

Sort By:
Pageof 24
Journal of Autoimmunity|February 13, 2026
Multiple sclerosis-associated EBNA2 variants influence the response to peginterferon beta-1a therapyCaterina Veroni, Fortunata Carbone, Daniela Ricci, et al.
European Journal of Neurology|May 8, 2023
Antibody response elicited by the SARS-CoV-2 vaccine booster in patients with multiple sclerosis: Who gains from it?Irene Schiavetti, Matilde Inglese, Jessica Frau, et al.
Neurology|June 8, 2018
Fingolimod vs dimethyl fumarate in multiple sclerosis: A real-world propensity score-matched studyLuca Prosperini, Matteo Lucchini, Shalom Haggiag, et al.
Journal of Neurology|March 28, 2022
Correction to: Prevalence and predictors of bowel dysfunction in a large multiple sclerosis outpatient population: an Italian multicenter studyAlvino Bisecco, Arianna Fornasiero, Assunta Bianco, et al.
CNS Drugs|July 20, 2018
Safety and Efficacy of Dimethyl Fumarate in Multiple Sclerosis: An Italian, Multicenter, Real-World StudyMassimiliano Mirabella, Luca Prosperini, Matteo Lucchini, et al.
Neurology|March 6, 2015
Epstein-Barr virus genetic variants are associated with multiple sclerosisRosella Mechelli, Caterina Manzari, Claudia Policano, et al.
European Journal of Neurology|September 10, 2022
Signs and symptoms of COVID-19 in patients with multiple sclerosisIrene Schiavetti, Luca Carmisciano, Marta Ponzano, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 20, 2022
Anti-SARS-CoV-2 T-stem cell memory persists in ocrelizumab-treated MS patientsGisella Guerrera, Alessandra Mandelli, Annamaria Finardi, et al.
Frontiers in Immunology|August 18, 2022
Proinflammatory mucosal-associated invariant CD8+ T cells react to gut flora yeasts and infiltrate multiple sclerosis brainFrancesca Gargano, Gisella Guerrera, Eleonora Piras, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 1, 2021
Charting a global research strategy for progressive MS-An international progressive MS Alliance proposalAlan J Thompson, William Carroll, Olga Ciccarelli, et al.
Pageof 24